Accenture (ACN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
1 Dec, 2025Executive summary
Achieved strong Q2 FY25 results with $16.7B revenue, up 8.5% in local currency and 5% in USD, driven by broad-based growth across geographies and industries, and continued market share gains.
Bookings reached $20.9B, with 32 clients each exceeding $100M in quarterly bookings; GenAI bookings were $1.4B and revenue $600M.
Adjusted Q2 FY25 EPS was $2.82, up 2% year-over-year; GAAP EPS up 7%.
Significant investments in strategic acquisitions, workforce training, and expansion of data and AI capabilities, with workforce growing to 801,000 and 72,000 in data and AI roles.
Recognized for ethical leadership and industry reputation, maintaining top rankings in multiple global lists.
Financial highlights
Q2 revenue: $16.7B, up 5% in USD and 8.5% in local currency year-over-year.
Operating margin: 13.5%, down 20 bps from adjusted Q2 last year; gross margin: 29.9% vs. 30.9% last year.
Diluted EPS: $2.82, up 2% over adjusted Q2 FY24 and 7% over GAAP; free cash flow: $2.7B.
Cash returned to shareholders: $2.4B via repurchases and dividends; cash balance at $8.5B.
Net income for Q2 FY25 was $1.82B, up from $1.67B year-over-year.
Outlook and guidance
Q3 FY25 revenue expected at $16.9B–$17.5B, with 3–7% local currency growth and -0.5% FX impact.
FY25 revenue growth guidance raised to 5–7% in local currency; EPS expected at $12.55–$12.79, up 5–7% over adjusted FY24.
Operating margin for FY25 expected at 15.6–15.7%, a 10–20 bps expansion; free cash flow guidance: $8.8B–$9.5B.
Inorganic contribution to revenue: just over 3% for FY25; $2–$3B planned for acquisitions.
Updated fiscal 2025 outlook provided, reflecting recent performance and market conditions.
Latest events from Accenture
- Q2 FY26 delivered record bookings, 8% revenue growth, and higher shareholder returns.ACN
Q2 202619 Mar 2026 - AI strategy is evolving rapidly, with ROI, specialization, and change management as top priorities.ACN
Fireside chat18 Mar 2026 - Q3 bookings hit $21.1B, GenAI surged, and FY24 guidance signals steady growth.ACN
Q3 20243 Feb 2026 - Record bookings, margin expansion, and robust FY25 outlook highlight strong momentum.ACN
Q4 202420 Jan 2026 - Q1 FY25 revenue up 9% to $17.7B; EPS, margin, and dividend rose, outlook raised.ACN
Q1 202510 Jan 2026 - Revenue up 6%, bookings up 12%, adjusted EPS up 10%, strong cash flow and returns.ACN
Q1 202618 Dec 2025 - Board recommends all proposals amid strong performance, governance, and ESG focus.ACN
Proxy Filing12 Dec 2025 - Board recommends approval of all director, compensation, auditor, and share issuance proposals.ACN
Proxy Filing12 Dec 2025 - Proxy covers 2025 AGM proposals, board refresh, pay-for-performance, and ESG leadership.ACN
Proxy Filing1 Dec 2025 - Fiscal 2024 saw record bookings, board refreshment, and major ESG progress, with all proposals recommended for approval.ACN
Proxy Filing1 Dec 2025